In this study, we found that ypTNM, high post‐chemotherapy TIL, and increased CD4+TIL levels post‐chemotherapy were independent prognostic factors in patients with NCT‐NSCLC. The gene discussed is CD4; the disease is non-small cell lung carcinoma.